Partner with Hikma.
We offer high-quality manufacturing capabilities, combining reliability and flexibility in our state-of-the-art facilities. With 30 manufacturing plants strategically located across the US, Europe, and the MENA region, we ensure that your needs are met with excellence.
Newsroom
All news stories Latest news
- Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products Press Release, Product 12 December 2024 Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products
- Hikma launches Furosemide Injection, USP, in the US Press Release, Product 09 December 2024 Hikma launches Furosemide Injection, USP, in the US
- Sell-side analysts and investors visit Hikma Casablanca site Press Release, Corporate 14 November 2024 Sell-side analysts and investors visit Hikma Casablanca site
- Hikma continues strong strategic execution and reiterates guidance Press Release, Financial Results 07 November 2024 Hikma continues strong strategic execution and reiterates guidance
Related content